Predictive socioeconomic and clinical profiles of antidepressant response and remission

Depression and Anxiety

Volumn 30, Issue 7, 2013, Pages 624-630

  Jain, Felipe A ^a   Hunter, Aimee M ^a   Brooks III, John O ^a   Leuchter, Andrew F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antidepressants; anxiety anxiety disorders; clinical trials; depression, gender; pharmacotherapy; treatment

Indexed keywords

CITALOPRAM;

ADULT; AGED; ALGORITHM; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; EFFECT SIZE; FEMALE; HAMILTON SCALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; QUICK INVENTORY DEPRESSIVE SYMPTOM SELF REPORT; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; REMISSION; SELF REPORT; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SOCIAL STATUS; SOCIOECONOMICS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSANTS; ANXIETY/ANXIETY DISORDERS; CLINICAL TRIALS; DEPRESSION, GENDER; PHARMACOTHERAPY; TREATMENT;

ADULT; ALGORITHMS; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SIGNAL DETECTION, PSYCHOLOGICAL; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 84879782531     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22045     Document Type: Article

References (50)

1. Kessler RC, Ormel J, Petukhova M, et al. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry 2011; 68: 90-100.
2. Clark HA,. Depression and narrative: telling the dark. Albany, NY: SUNY Press; 2008.
3. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262: 914-919.
4. National Center for Health Statistics. Health, United States, 2010: With special feature on death and dying. Table 95. Hyatsville, MD; 2011.
5. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40.
6. Carter GC, Cantrell RA, Victoria Z, et al. Comprehensive review of factors implicated in the heterogeneity of response in depression. Depress Anxiety 2012; 29: 340-354.
7. Bielski RJ, Friedel RO,. Prediction of tricyclic antidepressant response: a critical review. Arch Gen Psychiatry 1976; 33: 1479-1489.
8. Hirschfeld RM, Russell JM, Delgado PL, et al. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry 1998; 59: 669-675.
9. Saghafi R, Brown C, Butters MA, et al. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Int J Geriatr Psychiatry 2007; 22: 1141-1146.
10. Raskin J, Xu JY, Kajdasz DK,. Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder. Int Psychogeriatr 2008; 20: 309-327.
11. Perlis RH, Alpert J, Nierenberg AA, et al. Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day. Acta Psychiatr Scand 2003; 108: 432-438.
12. Young EA, Kornstein SG, Marcus SM, et al. Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res 2009; 43: 503-511.
13. Leuchter AF, Husain MM, Cook IA, et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychol Med 2010; 40: 239-251.
14. Silverstein B, Patel P,. Poor response to antidepressant medication of patients with depression accompanied by somatic symptomatology in the STAR*D Study. Psychiatry Res 2011; 187: 121-124.
15. Davis LL, Wisniewski SR, Howland RH, et al. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. Drug Alcohol Depend 2010; 107: 161-170.
16. Stewart JW, McGrath PJ, Fava M, et al. Do atypical features affect outcome in depressed outpatients treated with citalopram ? Int J Neuropsychopharmacol 2010; 13: 15-30.
17. McGrath PJ, Khan AY, Trivedi MH, et al. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. J Clin Psychiatry 2008; 69: 1847-1855.
18. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 2003; 26: 457-494.
19. Gorwood P, Rouillon F, Even C, et al. Treatment response in major depression: effects of personality dysfunction and prior depression. Br J Psychiatry 2010; 196: 139-142.
20. Trivedi MH, Morris DW, Pan JY, et al. What moderator characteristics are associated with better prognosis for depression? Neuropsychiatr Dis Treat 2005; 1: 51-57.
21. Friedman ES, Wisniewski SR, Gilmer W, et al. Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. Depress Anxiety 2009; 26: 612-621.
22. Zisook S, Trivedi MH, Warden D, et al. Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. J Affect Disord 2009; 117: 63-73.
23. Kraemer HC,. Evaluating Medical Tests: Objective and Quantitative Guidelines. Newbury Park, CA: Sage Publications, Inc.; 1992
24. Andreescu C, Mulsant BH, Houck PR, et al. Empirically derived decision trees for the treatment of late-life depression. Am J Psychiatry 2008; 165: 855-862.
25. Kiernan M, Kraemer HC, Winkleby MA, et al. Do logistic regression and signal detection identify different subgroups at risk? Implications for the design of tailored interventions. Psychol Methods 2001; 6: 35-48.
26. Jain FA, Brooks JO, 3rd, Larsen KA, et al. Individual risk profiles for postoperative delirium after joint replacement surgery. Psychosomatics 2011; 52: 410-416.
27. Rush AJ, Fava M, Wisniewski SR, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 2004; 25: 119-142.
28. Hamilton M,. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
29. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34: 73-82.
30. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-583.
31. Rosenthal R,. Parametric Measures of Effect Size. In:, Cooper HM, Hedges LV, editors. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994: 231-243.
32. Zimmerman M, Mattia JI,. The reliability and validity of a screening questionnaire for 13 DSM-IV axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry 1999; 60: 677-683.
33. Cleary P, Guy W,. Factor analysis of the Hamilton depression scale. Drugs Exp Clin Res 1977; 1: 115-120.
34. Bech P, Gram LF, Dein E, et al. Quantitative rating of depressive states. Acta Psychiatr Scand 1975; 51: 161-170.
35. Gibbons RD, Clark DC, Kupfer DJ,. Exactly what does the Hamilton Depression Rating Scale measure? J Psychiatr Res 1993; 27: 259-273.
36. Maier W, Philipp M,. Improving the assessment of severity of depressive states: a reduction of the Hamilton Depression Scale. Pharmacopsychiatry 1985; 18: 114-115.
37. Kuk AY, Li J, Rush AJ,. Recursive subsetting to identify patients in the STAR*D: a method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care. J Clin Psychiatry 2010; 71: 1502-1508.
38. Cohen A, Gilman SE, Houck PR, et al. Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 272-277.
39. American Psychiatric Association. Diagnostic Criteria from DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
40. U.S. Department of Health and Human Services. 2012 HHS Poverty Guidelines. http://aspe.hhs.gov/poverty/12poverty. shtml. Access Date: November 6, 2012.
41. Krause N,. Chronic financial strain, social support, and depressive symptoms among older adults. Psychol Aging 1987; 2: 185-192.
42. Lorant V, Croux C, Weich S, et al. Depression and socio-economic risk factors: 7-year longitudinal population study. Br J Psychiatry 2007; 190: 293-298.
43. Lorant V, Deliege D, Eaton W, et al. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 2003; 157: 98-112.
44. Drago A, Serretti A,. Sociodemographic features predict antidepressant trajectories of response in diverse antidepressant pharmacotreatment environments: a comparison between the STAR*D study and an independent trial. J Clin Psychopharmacol 2011; 31: 345-348.
45. Steptoe A, Marmot M,. Socioeconomic status and coronary heart disease: a psychobiological perspective. Popul Dev Rev 2004; 30: 133-150.
46. Isaacs SL, Schroeder SA,. Class-the ignored determinant of the nation's health. N Engl J Med 2004; 351: 1137-1142.
47. Lantz PM, House JS, Lepkowski JM, et al. Socioeconomic factors, health behaviors, and mortality-Results from a nationally representative prospective study of US adults. JAMA 1998; 279: 1703-1708.
48. Cook JA, Lehman AF, Drake R, et al. Integration of psychiatric and vocational services: a multisite randomized, controlled trial of supported employment. Am J Psychiatry 2005; 162: 1948-1956.
49. Crowther R, Marshall M, Bond G, Huxley P,. Vocational rehabilitation for people with severe mental illness. Cochrane Database Syst Rev 2001: CD003080.
50. Arean PA, Gum A, McCulloch CE, et al. Treatment of depression in low-income older adults. Psychol Aging 2005; 20: 601-609.